Sciensus’ unique aseptic compounding pharmacy proposition
Sciensus’ aseptic compounding pharmacy service operates from a fully MS licensed unit using the latest technology and assurance practices. We deliver safe, sterile medications directly to patients’ homes as well as to hospital clinics to help the NHS and private healthcare providers improve access to treatment.
Patient demand for aseptic product continues to rise particularly within cancer due to raised awareness, better diagnosis and ever-growing new medicines to market. Then coupled with economic challenges and nursing resource across NHS and UK. Sciensus took this opportunity to improve access to vital medications by opening a dedicated aseptic compounding unit in 2020.
Our unit is fully licensed and makes use of the latest technology and assurance practices to aseptically prepare tailored medications for both NHS and privately funded patients. Many of these treatments go on to be administered to patients in their own homes thanks to our national network of specially trained nurses, but we also deliver directly to NHS and private hospitals to support in-clinic treatment.
What is aseptic compounding?
Aseptic compounding is the process of preparing sterile medications in a controlled environment to prevent contamination. It ensures that medications are free from harmful bacteria, viruses and other pathogens often at tailored or banded doses.
Aseptic techniques typically include specialised equipment, sterile ingredients and protective measures. It’s particularly important in the production of medications for patients with weakened immune systems such as those receiving chemotherapy or long-term intravenous therapy.
Sciensus’ unique aseptic compounding pharmacy proposition
Completed in May 2020 our fully MS licensed purpose-built aseptic compounding unit makes use of the latest technology and assurance practices to prepare safe, sterile and personalised medications for both NHS and privately funded patients. We supply over 400 regimens covering 125 different molecules, as well as many new immunotherapies.
Some of the unit’s key features include:
- Hydrogen peroxide gassing
- Continuous environmental sampling and monitoring
- Volumetrics and gravimetrics
- Paperless system
- Batch products
GDP-compliant distribution network
Innovative customisable end-to-end solutions
Established relationships with pharma companies
Meet our expert
Get in touch
Thank you for your interest in Sciensus. Whether you’re seeking information, partnership opportunities, or want to refer a patient, our dedicated team is here to assist you. Please fill out the form on the right, and one of our multi-lingual representatives will get in touch with you promptly.
Events
ASCO 2025
Sciensus will be attending the upcoming ASCO (American Society of Clinical Oncology). ASCO is one of the most influential events…
News
Sciensus achieves 95% patient satisfaction and record NPS
At Sciensus, delivering life-changing therapies is more than a service — it’s a commitment to the people behind every prescription.…
Blogs
Driving reimbursement success in Europe with real-world data
Andrew Cummins, Vice President Business Development, and Mathieu Loiseau, Director of Rare Clinical Services, spoke at the recent World Orphan…